[Chronic administration of intranasal beclomethasone (Beconasol), but not intranasal mometasone (Nasonex) slows growth in body height].
Fischer
J
J
Horten-Zentrum für praxisorientierte Forschung und Wissenstransfer, Postfach Nord, Zürich. joachim.fischer@dim.usz.ch
D000281:Administration, Intranasal; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001507:Beclomethasone / Q000008:administration & dosage / Q000009:adverse effects*; D001827:Body Height / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008134:Long-Term Care; D008297:Male; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000008:administration & dosage / Q000009:adverse effects*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D001507:Beclomethasone